154 related articles for article (PubMed ID: 33288592)
1. Survival and Surgical Complications in Anaplastic Thyroid Cancer Patients After Completed Multimodal Treatment.
Lorntzsen B; Jacobsen AB; GrØholt KK; Sigstad E; Osnes T
Anticancer Res; 2020 Dec; 40(12):6979-6985. PubMed ID: 33288592
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.
Jacobsen AB; Grøholt KK; Lorntzsen B; Osnes TA; Falk RS; Sigstad E
Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4203-4209. PubMed ID: 29019001
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of radiotherapy in anaplastic thyroid cancer.
Dumke AK; Pelz T; Vordermark D
Radiat Oncol; 2014 Mar; 9(1):90. PubMed ID: 24685141
[TBL] [Abstract][Full Text] [Related]
4. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy.
Foote RL; Molina JR; Kasperbauer JL; Lloyd RV; McIver B; Morris JC; Grant CS; Thompson GB; Richards ML; Hay ID; Smallridge RC; Bible KC
Thyroid; 2011 Jan; 21(1):25-30. PubMed ID: 21162687
[TBL] [Abstract][Full Text] [Related]
5. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.
Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447
[TBL] [Abstract][Full Text] [Related]
6. Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between 1999 and 2012.
Brignardello E; Palestini N; Felicetti F; Castiglione A; Piovesan A; Gallo M; Freddi M; Ricardi U; Gasparri G; Ciccone G; Arvat E; Boccuzzi G
Thyroid; 2014 Nov; 24(11):1600-6. PubMed ID: 25110922
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of combined treatment for anaplastic thyroid carcinoma: results of a multinstitutional retrospective analysis.
Conzo G; Polistena A; Calò PG; Bononi P; Gambardella C; Mauriello C; Tartaglia E; Avenia S; Sanguinetti A; Medas F; de Toma G; Avenia N
Int J Surg; 2014; 12 Suppl 1():S178-82. PubMed ID: 24866070
[TBL] [Abstract][Full Text] [Related]
8. Results of combined treatment of anaplastic thyroid carcinoma (ATC).
Derbel O; Limem S; Ségura-Ferlay C; Lifante JC; Carrie C; Peix JL; Borson-Chazot F; Bournaud C; Droz JP; de la Fouchardière C
BMC Cancer; 2011 Nov; 11():469. PubMed ID: 22044775
[TBL] [Abstract][Full Text] [Related]
9. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study.
Lee JH; Ahn HK; Seok JY; Lee KC; Chun YS; Chung YS; Lee YD
Medicine (Baltimore); 2018 Jun; 97(25):e11037. PubMed ID: 29923991
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
Rao SN; Zafereo M; Dadu R; Busaidy NL; Hess K; Cote GJ; Williams MD; William WN; Sandulache V; Gross N; Gunn GB; Lu C; Ferrarotto R; Lai SY; Cabanillas ME
Thyroid; 2017 May; 27(5):672-681. PubMed ID: 28068873
[TBL] [Abstract][Full Text] [Related]
11. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
[TBL] [Abstract][Full Text] [Related]
12. A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.
Chintakuntlawar AV; Yin J; Foote RL; Kasperbauer JL; Rivera M; Asmus E; Garces NI; Janus JR; Liu M; Ma DJ; Moore EJ; Morris JC; Neben-Wittich M; Price DL; Price KA; Ryder M; Van Abel KM; Hilger C; Samb E; Bible KC
Thyroid; 2019 Nov; 29(11):1615-1622. PubMed ID: 31595822
[No Abstract] [Full Text] [Related]
13. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group.
Tennvall J; Lundell G; Hallquist A; Wahlberg P; Wallin G; Tibblin S
Cancer; 1994 Aug; 74(4):1348-54. PubMed ID: 8055459
[TBL] [Abstract][Full Text] [Related]
14. The rationale to switch from postoperative hyperfractionated accelerated radiotherapy to preoperative hyperfractionated accelerated radiotherapy in rectal cancer.
Coucke PA; Sartorelli B; Cuttat JF; Jeanneret W; Gillet M; Mirimanoff RO
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):181-8. PubMed ID: 7721615
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer.
Käsmann L; Bolm L; Janssen S; Rades D
Anticancer Res; 2016 Sep; 36(9):4697-700. PubMed ID: 27630315
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival--a single centre experience and review of the literature.
Lowe NM; Loughran S; Slevin NJ; Yap BK
ScientificWorldJournal; 2014; 2014():674583. PubMed ID: 25184150
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and prognosis of anaplastic thyroid carcinoma].
Wang JF; Zhu XH; Tan Z; Ge MH
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):434-438. PubMed ID: 28635233
[No Abstract] [Full Text] [Related]
18. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
[TBL] [Abstract][Full Text] [Related]
19. Survival and Prognostic Factors of Anaplastic Thyroid Carcinoma.
Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
Acta Chir Belg; 2015 Jan; 115(1):62-7. PubMed ID: 27384898
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
